Assessment of Botulinum Toxin Type A in the Treatment of Hand Eczema
Not Applicable
- Conditions
- Skin and Connective Tissue DiseasesHand Eczema
- Registration Number
- PACTR201704002194318
- Lead Sponsor
- Dermatology Department, Faculty of Medicine, University of Alexandria
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Active symptomatic palmar hand eczema.
Bilateral involvement.
Exclusion Criteria
Skin infection at the site of injection.
History of use of botulinum toxin in the last 4 months.
Pregnancy, lactation in females.
Any contraindication to botulinum toxin injection including associated disorder that may affect the neuromuscular function like myasthenia gravis and Lambert-Eaton disease.
History of previous allergy to BTXA.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method